Sep 29, 2020
Inovio’s shares plunge after FDA holds-off its COVID-19 vaccine Phase II/III trial Inovio’s COVID-19 vaccine, INO-4800, Phase II/III clinical trials’ have been put under partial hold after the USFDA raised questions. The firm mentioned the reason behind the halt of the trials is not due to adverse events i...
Read More...
Oct 10, 2024
The present Glioblastoma multiforme (GBM) market has several unmet needs. Poor prognosis, 10-15 months median survival rate, no curative treatment to the patients, limited treatment options, drug resistance, incapability of therapies to cross BBB (blood-brain-barrier), intratumor heterogeneity, and a high mortality...
Read More...
Oct 10, 2024
Headaches, blurred vision, nausea, lack of appetite, and mood swings. Sound familiar? These are common complaints that most of us shrug off as stress or fatigue. However, these seemingly minor issues are also early glioblastoma symptoms, warning signs of one of the most aggressive and deadly forms of brain cancer—g...
Read More...
Sep 24, 2020
J&J commences COVID-19 vaccine phase 3 Johnson & Johnson has begun a 60,000-subject phase 3 evaluation of its COVID-19 vaccine. The trial will enroll participants in the U.S. and other countries with a high incidence of COVID-19 to generate data to bolster emergency use authorization early next year. ...
Read More...
Sep 23, 2020
The amalgamation of technology and healthcare beholds tremendous opportunities to provide high-quality and affordable healthcare services. For the past few years, global healthcare companies are exploring Information and Communication Technologies (ICTs) to support and promote remote healthcare services and also to...
Read More...
Sep 22, 2020
Samsung Biologics strikes a USD 330.8 Mn supply deal with AstraZeneca Samsung Biologics announced the conclusion of a long-term supply deal with AstraZeneca worth USD 330.8 Million. AZ has made several headlines the past few months, forming a slew of deals to manufacture and supply its products. H...
Read More...
Sep 21, 2020
Each year, approximately 1.35 million people die due to vehicular or road accidents. Road crashes are also the most common cause of peripheral nerve injury (PNI), affecting the brachial BP or the radial, fibular, or sciatic nerves, typically in young motorcycle riders. These fragile and delicate nerves can be easil...
Read More...
Nov 07, 2024
Cervical cancer is the fourth most common type of cancer and the fourth leading cause of death in women. According to the WHO, HPV infections contribute to an estimated 530,000 cases of cervical cancer and 264,000 related deaths annually, with over 85% of these fatalities occurring in low- and middle-income countri...
Read More...
Sep 17, 2020
Lilly links COVID-19 antibody to a reduce hospitalization rate Eli Lilly has linked its anti-SARS-CoV-2 antibody to a lower rate of hospitalization in patients lately diagnosed with mild to moderate cases of COVID-19. Nevertheless, two of the three doses, including the highest studied in the phase 2 trial, flunk...
Read More...
Sep 16, 2020
In today’s highly dynamic world, almost every industry is going through major transformations. Similar to other industries, the healthcare sector has also observed many changes during the last two decades. The artificial intelligence, telemedicine, telehealth, 3D-printing, robotics/ nanotechnology, augmented realit...
Read More...